6.39 -0.02 (-0.31%)
OMER
| Trade OMER now with |
|
Stock Details
Last Trade:6.39 Change:-0.02 (-0.31%) Prev Close:6.41 Open: 6.36 Days Range:6.24 – 6.44 52 Week Range: 3.16 - 8.00 Volume:41251 P/E: N/AEPS:-1.17
View AllRecent Alerts 02/09/12
Recent Alert on 02/07/12 at 7:14am
Omeros (OMER) to Revise Expectations for OMS302; May Expand Indication
Omeros (OMER) to Revise Expectations for OMS302; May Expand Indication
Omeros Corporation (Nasdaq: OMER) reports that recent positive clinical developments have allowed it to revise the planned analysis for its ongoing Phase 3 clinical trial evaluating OMS302, which Omeros believes expands opportunities for the... Read More
Recent Alert on 02/07/12 at 7:14am
Omeros (OMER) to Revise Expectations for OMS302; May Expand Indication
Omeros (OMER) to Revise Expectations for OMS302; May Expand Indication
Recent Alert on 01/10/12 at 1:43pm
Unusual 11 Midday Movers 01/10: (OMER) (VOXX) (CRL) (PWRD) Higher; (WBMD) (HMA) (GNOM) (HITK) Lower
Unusual 11 Midday Movers 01/10: (OMER) (VOXX) (CRL) (PWRD) Higher; (WBMD) (HMA) (GNOM) (HITK) Lower
Recent Alert on 01/10/12 at 7:11am
Omeros Corp. (OMER) IDs Several New Compounds, Brings GPCRs to 23
Omeros Corp. (OMER) IDs Several New Compounds, Brings GPCRs to 23
Recent Alert on 01/10/12 at 7:11am
Omeros Corp. (OMER) IDs Several New Compounds, Brings GPCRs to 23
Omeros Corp. (OMER) IDs Several New Compounds, Brings GPCRs to 23
View AllRecent Press Releases
Press Release on 02/08/12 at 7:00am
Omeros to Present at the 14th Annual BIO CEO & Investor Conference
Omeros to Present at the 14th Annual BIO CEO & Investor Conference
View AllRecent SEC Filings
No Recent SEC Filings Available